• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 血清抗体在眼科参考中心医护人员中的流行率:一项横断面研究。

SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.

机构信息

Research Unit, Institute of Ophthalmology, Conde De Valenciana Foundation. Chimalpopoca, Mexico City, Mexico.

Laboratorio De Inmunología, Centro De Investigación En Alimentación Y Desarrollo, A.c, Hermosillo, Sonora Mexico.

出版信息

Ophthalmic Epidemiol. 2022 Oct;29(5):483-490. doi: 10.1080/09286586.2021.1974493. Epub 2021 Sep 16.

DOI:10.1080/09286586.2021.1974493
PMID:34530684
Abstract

PURPOSE

During the COVID-19 pandemic, healthcare workers (HCWs) are at a considerable risk of being infected with SARS-CoV-2; among them, HCWs from ophthalmology departments are more prone to develop severe symptoms. In Mexico City, the prevalence of SARS-CoV-2 infection among HCWs is 30%. The present work aims to describe the seroprevalence among HCWs at an Ophthalmological Reference Centre in Mexico City.

METHODS

A self-report questionnaire, RT-PCR test and detection of serum IgG/IgM antibodies against SARS-CoV-2 were performed among HCWs at the Institute of Ophthalmology "Conde de Valenciana".

RESULTS

A total of 169 HCWs participated in the study. None of the participants declared severe symptoms, and only 15% showed three or more symptoms. The results showed that 32% of the participants were RT-PCR (54/169), and 20% (35/169) presented IgG antibodies against SARS-CoV-2. Thirteen percent of the RT-PCR subjects were IgG positive, and 7.6% of the RT-PCR participants were IgG positive. The presence of three or more symptoms correlated with the presence of IgG antibodies, as well as Ct values of < 32 ( < 0,05).

CONCLUSION

Most of the HCW cohort showed mild symptoms, and 69% of the RT-PCR participants did not show IgG antibodies against SARS-CoV-2. Seroprevalence was significantly associated with the presentation of COVID-19-associated symptoms.

摘要

目的

在 COVID-19 大流行期间,医护人员(HCWs)感染 SARS-CoV-2 的风险相当大;其中,眼科部门的 HCWs 更容易出现严重症状。在墨西哥城,HCWs 中 SARS-CoV-2 感染的患病率为 30%。本研究旨在描述墨西哥城一家眼科参考中心的 HCWs 的血清阳性率。

方法

在“Conde de Valenciana”眼科研究所对 HCWs 进行了自我报告问卷、RT-PCR 检测和 SARS-CoV-2 血清 IgG/IgM 抗体检测。

结果

共有 169 名 HCWs 参与了这项研究。没有参与者报告严重症状,只有 15%的参与者出现了三种或三种以上的症状。结果表明,32%的参与者 RT-PCR 检测呈阳性(54/169),20%(35/169)的人对 SARS-CoV-2 产生 IgG 抗体。13%的 RT-PCR 阳性者 IgG 呈阳性,7.6%的 RT-PCR 阳性者 IgG 呈阳性。出现三种或三种以上症状与 IgG 抗体的存在以及 Ct 值<32(<0.05)相关。

结论

大多数 HCW 队列表现出轻度症状,69%的 RT-PCR 参与者未显示针对 SARS-CoV-2 的 IgG 抗体。血清阳性率与 COVID-19 相关症状的出现显著相关。

相似文献

1
SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.SARS-CoV-2 血清抗体在眼科参考中心医护人员中的流行率:一项横断面研究。
Ophthalmic Epidemiol. 2022 Oct;29(5):483-490. doi: 10.1080/09286586.2021.1974493. Epub 2021 Sep 16.
2
Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.哥伦比亚医护人员在 COVID-19 大流行期间的血清流行率、感染率和个人防护设备使用情况。
Front Public Health. 2023 Oct 10;11:1225037. doi: 10.3389/fpubh.2023.1225037. eCollection 2023.
3
Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.爱尔兰南部一家三级医院在 COVID-19 大流行第一波后医护人员中 SARS-CoV-2 抗体的血清阳性率研究。
BMJ Open. 2021 Jun 8;11(6):e051415. doi: 10.1136/bmjopen-2021-051415.
4
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.在瑞典低流行地区,与老年护理人员相比,医院医护人员的 SARS-CoV-2 IgG 血清阳性率更高:一项横断面研究。
Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5.
5
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.波兰一家儿科三级医院医护人员中针对 SARS-CoV-2 的 IgG 抗体流行率。
PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021.
6
Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.墨西哥城 COVID-19 大流行第一波期间医护人员感染 SARS-CoV-2 后的抗体反应特征。
J Int Med Res. 2022 Jul;50(7):3000605221099458. doi: 10.1177/03000605221099458.
7
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
8
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
9
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.伊朗德黑兰有新冠患者转诊的主要私立和公立医院中卫生保健工作者的 SARS-CoV-2 血清流行率。
Front Public Health. 2022 Mar 24;10:832003. doi: 10.3389/fpubh.2022.832003. eCollection 2022.
10
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间,一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异:canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.

引用本文的文献

1
SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review.接种新冠疫苗的医护人员中出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗突破性感染:一项系统综述
Trop Med Infect Dis. 2022 Jan 13;7(1):9. doi: 10.3390/tropicalmed7010009.